Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

1(33.3%)

Phase 3

1(33.3%)

N/A

1(33.3%)

3Total

Phase 2(1)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT01616784Phase 3Completed

The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial

Role: collaborator

NCT01795833Not ApplicableCompleted

Diabetes Prevention Using SMS Technology

Role: collaborator

NCT03321578Completed

Hospital Onset Diarrhoea Investigation

Role: collaborator

NCT02333123Phase 2Terminated

Aspirin for Venous Ulcers: Randomised Trial (AVURT)

Role: collaborator

All 4 trials loaded